![Kristen de Almeida PharmD, BCCP Profile](https://pbs.twimg.com/profile_images/1219460685387702274/yE3CaD9j_x96.jpg)
Kristen de Almeida PharmD, BCCP
@CardioPharmRx
Followers
60
Following
445
Statuses
113
RT @SCAI: Are you curious about the latest in @MyJSCAI? Editor-in-Chief @AlexandraLansky, shares the year in review. Follow this thread for…
0
3
0
RT @AnticoagForum: Join us Tues 9/7 2pm ET & learn about "Reducing Health Disparities—Achieving Pharmacoequity" Dr. Utibe R. Essien will wa…
0
4
0
RT @TCTMD: ATTRibute-CM Top-Line Results Favorable for Acoramidis in Transthyretin Amyloidosis
0
3
0
RT @AminYehyaMD: The standards, competencies, & clinical data relating to the use of device therapy in heart failure (HF) continue to evolv…
0
3
0
RT @DrDapo: Based on some recent Twitter debates, went back to review some of the data on CT Calcium Scoring as a predictor of MACE. Here'…
0
8
0
RT @RyanTedfordMD: Happy to share our #ThePeoplesVentricle review out today in @NEJM. We hope this is approachable and useful for all phys…
0
314
0
RT @HanCardiomd: #Inotropic therapy in patients with advanced #HeartFailure A clinical consensus statement from the Heart Failure Associa…
0
62
0
RT @AHajduczok: Do you ❤️ hemodynamics? How about PV loops? Here is Part I of our journey to to help YOU better understand PV loops and ma…
0
740
0
RT @AHAScience: 🆕 statement explores past, present & future of surgical management of high-risk PE, a leading cause of CV death in the U.S.…
0
6
0
RT @akhadilkarMD: As a Cardiology fellow, we get a lot of consults for Cardiogenic Shock. Part 1: Definition/Pathophysiology. *Not to u…
0
80
0
RT @FeliceGragnano: How to manage patients with left ventricular thrombosis? This review article provides #new solutions to an #old problem…
0
42
0
RT @dr_benoy_n_shah: #ESCCongress Let's get straight to the point about #INVICTUS The only people not surprised by the results are imag…
0
292
0
RT @EiranGorodeski: Heart Failure Grand Rounds #HarringtonHVI @UHhospitals featuring today Dr. Jeffrey Testani. Cardio-Renal Syndrome and D…
0
28
0
RT @HanCardiomd: Conventional sequencing is inefficient, time-consuming and does not allow patients to receive the early reductions in even…
0
16
0
RT @ANazmiCalik: #ESCCongress Day 1 Hot Lines 🔥 🫀TIME ➡️ 🌞 vs 🌚 anti HT 💊 is similar for ⬇️ MI, stroke and CV 💀 🫀SECURE ➡️ Polypill (ASA+…
0
30
0